论文部分内容阅读
对影响心肌梗塞后预后因素的估价在病人的管理、心肌梗塞后治疗的临床试验设计、阐明心肌梗塞后死亡机理、以及心肌梗塞后同类病人疗效的比较等方面很为有用。然而,过去对这些预后因素的研究缺乏一致性,使其有用性受到限制。产生不一致的最重要原因是不同的见解、较差的统计方法、以及对因素的不同定义和衡量。本文报告1971年 Perth冠心病登记(PCR)中666例急性心肌梗塞后存活病例的9年随诊结果。方法:PCR 是 WHO 在欧洲、以色列和澳大利亚19个中心合作调查心肌梗塞发生率的一个部分。PCR 有239,546名30～69岁人群,其中1,138次最后确诊或为可能心肌梗塞,发生于1,078例病人。此1,078例从最早登记日起随诊至1979年12
Valuation of the prognostic factors affecting myocardial infarction is useful in patient management, clinical trial design for post-MI treatment, elucidation of the mechanism of post-MI death, and comparison of outcomes among similar patients after myocardial infarction. However, the lack of consistency in the past studies of these prognostic factors has limited its usefulness. The most important reasons for inconsistencies are different insights, poorer statistical methods, and different definitions and measures of factors. This article reports the 9-year follow-up of 666 survivors of acute myocardial infarction in the 1971 Perth Coronary Registry. Methods: PCR is part of the WHO collaborative investigation of the incidence of myocardial infarction in 19 centers in Europe, Israel and Australia. There were 239,546 people aged 30-69 years with PCR, 1,138 of whom were finally diagnosed as probable myocardial infarctions and 1,078 patients. The 1,078 cases were followed up from 1979 to the date of their registration